Stockscreener 앱 받기
1.38
0.72%
-0.01
전일 마감가:
$1.39
열려 있는:
$1.39
하루 거래량:
2.78M
Relative Volume:
1.16
시가총액:
$1.06B
수익:
$711.41M
순이익/손실:
$-133.73M
주가수익비율:
-7.2632
EPS:
-0.19
순현금흐름:
$-199.99M
1주 성능:
+2.99%
1개월 성능:
+4.55%
6개월 성능:
+2.99%
1년 성능:
-14.29%
1일 변동 폭
$1.35
$1.4191
1주일 범위
$1.28
$1.4191
52주 변동 폭
$1.11
$2.035
Opko Health Inc Stock (OPK) Company Profile
명칭
Opko Health Inc
전화
305-575-4181
주소
4400 BISCAYNE BLVD., MIAMI, FL
OPK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.38 | 1.07B | 711.41M | -133.73M | -199.99M | -0.19 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-20 | 개시 | JP Morgan | Neutral |
| 2025-10-31 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-25 | 개시 | JP Morgan | Neutral |
| 2023-06-29 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-12-15 | 개시 | H.C. Wainwright | Buy |
| 2022-01-24 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-06-21 | 개시 | Ladenburg Thalmann | Buy |
| 2019-11-25 | 개시 | Piper Jaffray | Overweight |
| 2018-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-09-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2016-06-21 | 재확인 | Standpoint Research | Buy |
| 2016-06-03 | 개시 | Standpoint Research | Buy |
| 2016-03-31 | 재확인 | Barrington Research | Outperform |
| 2015-10-16 | 개시 | JP Morgan | Overweight |
| 2015-09-11 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-03-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2014-05-12 | 재확인 | Oppenheimer | Outperform |
| 2014-03-14 | 개시 | Oppenheimer | Outperform |
| 2013-11-13 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-05-30 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-10-22 | 개시 | Barrington Research | Outperform |
| 2011-12-01 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-07-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
Opko Health Inc 주식(OPK)의 최신 뉴스
Opko Health Inc.’s (OPK) ModeX Therapeutics Announces License and Collaboration Agreement With Regeneron Pharmaceuticals - MSN
Shorts Report: Why analysts upgrade OPKO Health Inc stockEarnings Growth Summary & Stock Portfolio Risk Management - BỘ NỘI VỤ
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now - Finviz
OPKO Health, Inc. (NASDAQ:OPK) Given Average Rating of "Hold" by Brokerages - MarketBeat
What analysts say about OPKO Health Inc stockBlue Chip Stock Analysis & Learn From the Strategies of Institutions - earlytimes.in
How OPKO Health Inc. (XCY) stock valuation compares with sectorWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Why pension funds invest in OPKO Health Inc. (XCY) stockEarnings Summary Report & Weekly Stock Performance Updates - Newser
How buyback programs support OPKO Health Inc. (XCY) stockQuarterly Trade Report & High Win Rate Trade Tips - Newser
Geode Capital Management LLC Increases Stake in OPKO Health, Inc. $OPK - MarketBeat
Is OPKO Health Inc. (XCY) stock suitable for passive index fundsJuly 2025 Sentiment & Smart Money Movement Alerts - Newser
What sentiment indicators say about OPKO Health Inc. stockFed Meeting & Risk Managed Investment Strategies - Newser
Aug Shorts: Is OPKO Health Inc. stock undervalued vs historical averages2025 Valuation Update & Fast Gaining Stock Reports - moha.gov.vn
Published on: 2025-11-28 01:47:51 - BỘ NỘI VỤ
OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Not Quite Adding Up - 富途牛牛
Opko’s OPK-88006 shows hepatoprotection in MASH - BioWorld MedTech
OPKO Health Swaps Lab Assets And Trims Costs For Steadier Profits - Finimize
XCY.DE Interactive Stock Chart | Opko Health, Inc. Stock - Yahoo Finance
OPKO Health (NASDAQ:OPK) CEO Acquires $771,400.00 in Stock - MarketBeat
Zacks Research Boosts Earnings Estimates for OPKO Health - MarketBeat
Chmn Frost Buys 580,000 ($768.8K) Of Opko Health Inc [OPK] - TradingView
OPKO Health (NASDAQ:OPK) Earns Neutral Rating from Analysts at JPMorgan Chase & Co. - MarketBeat
Will OPKO Health Inc. (XCY) stock attract long term capital inflowsJuly 2025 Summary & Daily Price Action Insights - newser.com
The Bull Case For OPKO Health (OPK) Could Change Following CEO Frost's Major Share Purchase Amid Downgrade - Yahoo Finance
Chmn Frost Buys 580,000 ($771.3K) Of Opko Health Inc [OPK] - TradingView
OPKO Health (NASDAQ:OPK) CEO Phillip Md Et Al Frost Purchases 580,000 Shares - MarketBeat
OPKO Health, Inc. announces an Increase in Equity Buyback. - MarketScreener
JP Morgan Initiates Coverage of OPKO Health (OPK) with Neutral Recommendation - MSN
JPMorgan initiates Opko Health stock with Neutral rating By Investing.com - Investing.com Canada
OPKO Health (OPK): Evaluating Valuation After Insider Buying and Sales Concerns on Ngenla - Yahoo Finance
Is OPKO Health Inc. building a consolidation baseWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Phillip Md Et Al Frost Purchases 533,300 Shares of OPKO Health (NASDAQ:OPK) Stock - MarketBeat
Opko Health Insider Bought Shares Worth $759,115, According to a Recent SEC Filing - MarketScreener
Chmn Frost Buys 580,000 ($759.1K) Of Opko Health Inc [OPK] - TradingView
Regression analysis insights on OPKO Health Inc. performanceDay Trade & Daily Profit Focused Screening - newser.com
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Is OPKO Health Inc. stock supported by strong fundamentalsWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
How reliable is OPKO Health Inc. (XCY) stock dividend growthGDP Growth & Reliable Intraday Trade Plans - newser.com
Will OPKO Health Inc. (XCY) stock benefit from Fed rate cuts2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Why analysts remain bullish on OPKO Health Inc. stockWall Street Watch & Stock Portfolio Risk Control - newser.com
Using Bollinger Bands to evaluate OPKO Health Inc.Recession Risk & Long-Term Capital Growth Strategies - newser.com
Opko Health Insider Bought Shares Worth $737,748, According to a Recent SEC Filing - MarketScreener
News impact scoring models applied to OPKO Health Inc.Market Performance Report & Weekly Breakout Opportunity Watchlist - newser.com
How OPKO Health Inc. (XCY) stock performs during market turbulence2025 Macro Impact & Verified Momentum Watchlists - newser.com
Will OPKO Health Inc. stock see insider buyingQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Risk vs reward if holding onto OPKO Health Inc.Gold Moves & Low Drawdown Trading Strategies - newser.com
Opko Health Inc (OPK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Opko Health Inc 주식 (OPK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 20 '25 |
Buy |
1.33 |
580,000 |
771,328 |
216,126,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 19 '25 |
Buy |
1.31 |
580,000 |
759,115 |
215,546,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Nov 18 '25 |
Buy |
1.27 |
533,300 |
678,906 |
214,966,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Oct 31 '25 |
Buy |
1.42 |
150,000 |
213,435 |
214,386,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Aug 08 '25 |
Buy |
1.32 |
675,000 |
891,000 |
214,676,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 10 '25 |
Buy |
1.36 |
125,000 |
169,712 |
214,001,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 08 '25 |
Buy |
1.48 |
125,000 |
184,650 |
213,876,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Apr 01 '25 |
Buy |
1.65 |
100,000 |
164,850 |
213,751,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 28 '25 |
Buy |
1.70 |
150,000 |
254,385 |
213,651,448 |
| FROST PHILLIP MD ET AL | CEO & Chairman |
Mar 17 '25 |
Buy |
1.74 |
200,000 |
347,820 |
213,501,448 |
1.15%
0.39%
자본화:
|
볼륨(24시간):